Guest guest Posted May 20, 2011 Report Share Posted May 20, 2011 4 new articles Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN–191/RG7227) leads to robust reductions in viral RNA: A phase 1b multiple ascending dose study Journal of Hepatology Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration Full Text International Braz J Urol Boceprevir approved for treating hepatitis C Full Text American Pharmacists Association Hepatitis c recurrence after liver transplantation: has the hla mismatching at individual loci a role Journal of Gastroenterology and Hepatology Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.